Effects of statins on intramuscular interferon beta-1a for relapsing-remitting multiple sclerosis

被引：0
|
作者：
Rudick, R.
Pace, A.
Panzara, M.
Rani, S.
Schrock, J.
Calabresi, F.
Confavreux, C.
Galetta, S.
Lublin, F.
Radue, E. W.
Stuart, W.
Weinstock-Guttman, B.
Wynn, D.
机构：
[1] Cleveland Clin Fdn, Cleveland, OH 44195 USA
[2] Biogen Idec Inc, Cambridge, MD USA
[3] Johns Hopkins Multiple Sclerosis Ctr, Baltimore, MD USA
[4] Hop Neurol, Lyon, France
[5] Univ Penn, Sch Med, Philadelphia, PA 19104 USA
[6] Mt Sinai Sch Med, New York, NY USA
[7] Univ Basel Hosp, CH-4031 Basel, Switzerland
[8] MS Ctr Atlanta, Atlanta, GA USA
[9] SUNY Buffalo, Buffalo, NY 14260 USA
来源：
MULTIPLE SCLEROSIS | 2007年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S57 / S57
页数：1
相关论文
共 50 条
  • [21] The use of interferon beta in relapsing-remitting multiple sclerosis
    Etheridge, LJ
    Beverley, DW
    Ferrie, C
    McManus, E
    [J]. ARCHIVES OF DISEASE IN CHILDHOOD, 2004, 89 (08) : 789 - 791
  • [22] Intramuscular interferon beta-1a therapy in patients with relapsing-remitting multiple sclerosis: a 15-year follow-up study
    Bermel, R. A.
    Weinstock-Guttman, B.
    Bourdette, D.
    Foulds, P.
    You, X.
    Rudick, R. A.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2010, 16 (05) : 588 - 596
  • [23] No evidence of disease activity in patients receiving daclizumab versus intramuscular interferon beta-1a for relapsing-remitting multiple sclerosis in the DECIDE study
    Kappos, Ludwig
    Havrdova, Eva
    Giovannoni, Gavin
    Khatri, Bhupendra O.
    Gauthier, Susan A.
    Greenberg, Steven J.
    You, Xiaojun
    Wang, Ping
    Giannattasio, Giorgio
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2017, 23 (13) : 1736 - 1747
  • [24] Comparison of fingolimod with interferon beta-1a in relapsing-remitting multiple sclerosis: a randomised extension of the TRANSFORMS study
    Khatri, Bhupendra
    Barkhof, Frederik
    Comi, Giancarlo
    Hartung, Hans-Peter
    Kappos, Ludwig
    Montalban, Xavier
    Pelletier, Jean
    Stites, Tracy
    Wu, Stacy
    Holdbrook, Fred
    Zhang-Auberson, Lixin
    Francis, Gordon
    Cohen, Jeffrey A.
    Cohen, J.
    Barkhof, F.
    Comi, G.
    Hartung, H.P.
    Khatri, B.
    Montalban, X.
    Pelletier, J.
    Easton, D.
    Calandra, T.
    DiMarco, J.
    Hudson, L.
    Kesselring, J.
    Laupacis, A.
    Temkin, N.
    Weinshenker, B.
    Zarbin, M.
    Barkhof, F.
    Poppe, P.
    Luetic, G.
    Cristiano, E.
    Caceres, F.
    Garcea, O.
    Correale, J.
    Ballario, C.
    Piedrabuena, R.
    Pollard, J.
    Beran, R.
    Hodgkinson, S.
    Schwartz, R.
    Heard, R.
    King, J.
    Butzkueven, H.
    Maida, E.M.
    Vass, K.
    Franta-Elmer, C.
    Berger, T.
    Aichner, F.
    [J]. LANCET NEUROLOGY, 2011, 10 (06): : 520 - 529
  • [25] Mycophenolate mofetil in combination with interferon beta-1a in the treatment of relapsing-remitting multiple sclerosis: a preliminary study
    Etemadifar, Masoud
    Kazemi, Mojtaba
    Chitsaz, Ahmad
    Hekmatnia, Ali
    Tayari, Nazila
    Ghazavi, Amirhossein
    Maghzi, Amir Hadi
    [J]. JOURNAL OF RESEARCH IN MEDICAL SCIENCES, 2011, 16 (01): : 1 - 5
  • [26] PAYER AND SOCIETAL BENEFIT OF PEGINTERFERON BETA-1A VERSUS SUBCUTANEOUS INTERFERON BETA-1A IN PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS IN ITALY
    Gitlin, M.
    Snyder, S.
    Jhaveri, M.
    [J]. VALUE IN HEALTH, 2019, 22 : S746 - S746
  • [27] PAYER AND SOCIETAL BENEFIT OF PEGINTERFERON BETA-1A VERSUS SUBCUTANEOUS INTERFERON BETA-1A IN PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS IN SPAIN
    Gitlin, M.
    Snyder, S.
    Jhaveri, M.
    [J]. VALUE IN HEALTH, 2019, 22 : S744 - S744
  • [28] Side effects of interferon-beta 1a in relapsing-remitting multiple sclerosis
    Lotfi, J
    Adibnejad, S
    Beheshtian, A
    [J]. JOURNAL OF NEUROLOGY, 2004, 251 : 64 - 64
  • [29] Binding and Neutralising Antibodies in Relapsing-remitting Multiple Sclerosis Patients Treated with a Biosimilar Interferon Beta-1a (CinnoVex®)
    Sh, Nafissi
    Shahkarami, M. Amir
    Lam, R.
    Oger, J.
    [J]. MULTIPLE SCLEROSIS, 2010, 16 (02): : 273 - 273
  • [30] Effects of immunomodulatory treatment with subcutaneous interferon beta-1a oncognitive decline in mildly disabled patients with relapsing-remitting multiple sclerosis
    Patti, F.
    Amato, M. P.
    Bastianello, S.
    Caniatti, L.
    Di Monte, E.
    Ferrazza, P.
    Goretti, B.
    Gallo, P.
    Morra, V. Brescia
    Lo Fermo, S.
    Picconi, O.
    Tola, M. R.
    Trojano, M.
    [J]. MULTIPLE SCLEROSIS, 2010, 16 (01): : 68 - 77
12345